Clinical Trial Update: JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating JS203 combination regimens for B-cell non-Hodgkin's lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• JS203

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: B-cell Non-Hodgkin's Lymphoma | Phase 2 | Status: RECRUITING